Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) -- -- 50% relative risk reduction of progression or death with ...

Beyond Cancer announced key data demonstrating the efficacy of Low Volume Ultra-High Concentration Nitric Oxide, LV UNO, when combined with ...

Fecal microbiota transplantation has significantly improved progression-free survival in patients with metastatic renal cell ...

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...

Source: Getty Images Clinicians should have a standard approach for discussing the risk of adverse events associated with immune checkpoint inhibitors, researchers say. The most common immune-related ...

As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T cells -; which have lost their cancer-fighting oomph -; consume this lactic ...

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

Additionally, positive findings from trials like ADRIATIC (NCT03703297) and IMforte (NCT05091567) are further shaping ...